Cargando…
Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)
PURPOSE: The outcome of RCC has improved considerably in the last few years, and the treatment options have increased. LACOG-GU and LARCG held a consensus meeting to develop guidelines to support the clinical decisions of physicians and other health professionals involved in the care of RCC patients...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256074/ https://www.ncbi.nlm.nih.gov/pubmed/32410064 http://dx.doi.org/10.1007/s00432-020-03236-4 |
| _version_ | 1783539840836435968 |
|---|---|
| author | Soares, Andrey Monteiro, Fernando Sabino Marques Maluf, Fernando Cotait Bastos, Diogo Assed Jardim, Denis Leonardo Sasse, André Deeke Gonçalves e Silva, Adriano Fay, André P. da Rosa, Diogo Augusto Rodrigues Wierman, Evanius Kater, Fabio Schutz, Fabio A. de Oliveira, Fernando Nunes Galvão Morbeck, Igor Alexandre Protzner Rinck, José Augusto da Trindade, Karine Martins Maia, Manuel Caitano Souza, Vinicius Carrera da Silva Neto, Deusdedit Cortez Vieira de Almeida e Paula, Felipe Korkes, Fernando Carvalhal, Gustavo Franco Nogueira, Lucas de Carvalho Fernandes, Roni dos Reis, Rodolfo Borges Matheus, Wagner Eduardo Busato, Wilson Francisco Schreiner da Costa, Walter Henriques de Cássio Zequi, Stênio |
| author_facet | Soares, Andrey Monteiro, Fernando Sabino Marques Maluf, Fernando Cotait Bastos, Diogo Assed Jardim, Denis Leonardo Sasse, André Deeke Gonçalves e Silva, Adriano Fay, André P. da Rosa, Diogo Augusto Rodrigues Wierman, Evanius Kater, Fabio Schutz, Fabio A. de Oliveira, Fernando Nunes Galvão Morbeck, Igor Alexandre Protzner Rinck, José Augusto da Trindade, Karine Martins Maia, Manuel Caitano Souza, Vinicius Carrera da Silva Neto, Deusdedit Cortez Vieira de Almeida e Paula, Felipe Korkes, Fernando Carvalhal, Gustavo Franco Nogueira, Lucas de Carvalho Fernandes, Roni dos Reis, Rodolfo Borges Matheus, Wagner Eduardo Busato, Wilson Francisco Schreiner da Costa, Walter Henriques de Cássio Zequi, Stênio |
| author_sort | Soares, Andrey |
| collection | PubMed |
| description | PURPOSE: The outcome of RCC has improved considerably in the last few years, and the treatment options have increased. LACOG-GU and LARCG held a consensus meeting to develop guidelines to support the clinical decisions of physicians and other health professionals involved in the care of RCC patients. METHODS: Eighty questions addressing relevant advanced RCC treatments were previously formulated by a panel of experts. The voting panel comprised 26 specialists from the LACOG-GU/LARCG. Consensus was determined as 75% agreement. For questions with less than 75% agreement, a new discussion was held, and consensus was determined by the majority of votes after the second voting session. RESULTS: The recommendations were based on the highest level of scientific evidence or by the opinion of the RCC experts when no relevant research data were available. CONCLUSION: This manuscript provides guidance for advanced RCC treatment according to the LACOG-GU/LARCG expert recommendations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-020-03236-4) contains supplementary material, which is available to authorized users. |
| format | Online Article Text |
| id | pubmed-7256074 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72560742020-06-08 Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) Soares, Andrey Monteiro, Fernando Sabino Marques Maluf, Fernando Cotait Bastos, Diogo Assed Jardim, Denis Leonardo Sasse, André Deeke Gonçalves e Silva, Adriano Fay, André P. da Rosa, Diogo Augusto Rodrigues Wierman, Evanius Kater, Fabio Schutz, Fabio A. de Oliveira, Fernando Nunes Galvão Morbeck, Igor Alexandre Protzner Rinck, José Augusto da Trindade, Karine Martins Maia, Manuel Caitano Souza, Vinicius Carrera da Silva Neto, Deusdedit Cortez Vieira de Almeida e Paula, Felipe Korkes, Fernando Carvalhal, Gustavo Franco Nogueira, Lucas de Carvalho Fernandes, Roni dos Reis, Rodolfo Borges Matheus, Wagner Eduardo Busato, Wilson Francisco Schreiner da Costa, Walter Henriques de Cássio Zequi, Stênio J Cancer Res Clin Oncol Review – Clinical Oncology PURPOSE: The outcome of RCC has improved considerably in the last few years, and the treatment options have increased. LACOG-GU and LARCG held a consensus meeting to develop guidelines to support the clinical decisions of physicians and other health professionals involved in the care of RCC patients. METHODS: Eighty questions addressing relevant advanced RCC treatments were previously formulated by a panel of experts. The voting panel comprised 26 specialists from the LACOG-GU/LARCG. Consensus was determined as 75% agreement. For questions with less than 75% agreement, a new discussion was held, and consensus was determined by the majority of votes after the second voting session. RESULTS: The recommendations were based on the highest level of scientific evidence or by the opinion of the RCC experts when no relevant research data were available. CONCLUSION: This manuscript provides guidance for advanced RCC treatment according to the LACOG-GU/LARCG expert recommendations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-020-03236-4) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-05-14 2020 /pmc/articles/PMC7256074/ /pubmed/32410064 http://dx.doi.org/10.1007/s00432-020-03236-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Review – Clinical Oncology Soares, Andrey Monteiro, Fernando Sabino Marques Maluf, Fernando Cotait Bastos, Diogo Assed Jardim, Denis Leonardo Sasse, André Deeke Gonçalves e Silva, Adriano Fay, André P. da Rosa, Diogo Augusto Rodrigues Wierman, Evanius Kater, Fabio Schutz, Fabio A. de Oliveira, Fernando Nunes Galvão Morbeck, Igor Alexandre Protzner Rinck, José Augusto da Trindade, Karine Martins Maia, Manuel Caitano Souza, Vinicius Carrera da Silva Neto, Deusdedit Cortez Vieira de Almeida e Paula, Felipe Korkes, Fernando Carvalhal, Gustavo Franco Nogueira, Lucas de Carvalho Fernandes, Roni dos Reis, Rodolfo Borges Matheus, Wagner Eduardo Busato, Wilson Francisco Schreiner da Costa, Walter Henriques de Cássio Zequi, Stênio Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) |
| title | Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) |
| title_full | Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) |
| title_fullStr | Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) |
| title_full_unstemmed | Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) |
| title_short | Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) |
| title_sort | advanced renal cell carcinoma (rcc) management: an expert panel recommendation from the latin american cooperative oncology group (lacog) and the latin american renal cancer group (larcg) |
| topic | Review – Clinical Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256074/ https://www.ncbi.nlm.nih.gov/pubmed/32410064 http://dx.doi.org/10.1007/s00432-020-03236-4 |
| work_keys_str_mv | AT soaresandrey advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT monteirofernandosabinomarques advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT maluffernandocotait advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT bastosdiogoassed advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT jardimdenisleonardo advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT sasseandredeeke advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT goncalvesesilvaadriano advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT fayandrep advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT darosadiogoaugustorodrigues advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT wiermanevanius advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT katerfabio advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT schutzfabioa advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT deoliveirafernandonunesgalvao advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT morbeckigoralexandreprotzner advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT rinckjoseaugusto advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT datrindadekarinemartins advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT maiamanuelcaitano advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT souzaviniciuscarrera advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT dasilvanetodeusdeditcortezvieira advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT dealmeidaepaulafelipe advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT korkesfernando advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT carvalhalgustavofranco advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT nogueiralucas advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT decarvalhofernandesroni advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT dosreisrodolfoborges advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT matheuswagnereduardo advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT busatowilsonfranciscoschreiner advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT dacostawalterhenriques advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg AT decassiozequistenio advancedrenalcellcarcinomarccmanagementanexpertpanelrecommendationfromthelatinamericancooperativeoncologygrouplacogandthelatinamericanrenalcancergrouplarcg |